KNSA
NASDAQ · Biotechnology
Kiniksa Pharmaceuticals Inte
$93.86
+5.52 (+6.25%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-22.6% upside
Low Target
$47.11
Average Target
$72.69
High Target
$100.82
Current Price
$93.86
Current
$93.86
$93.86
Target
$72.69
$72.69
$47.11
$72.69 avg
$100.82
Scenario Analysis
Bear Case
$47.11
-49.8%
Low target
Base Case
$72.69
-22.6%
Avg target
Bull Case
$100.82
+7.4%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$98.48
-4.7% from high
52-Week Low
$37.02
+153.5% from low
50-Day SMA
$80.46
+16.7% vs SMA
200-Day SMA
$61.50
+52.6% vs SMA
RSI (14)
60.9
Neutral
Target vs 52W High
$72.69
-26.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |